BioNTech SE (BNTX) Cash & Equivalents Growth (1y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | 12.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -28.32% |
| Sep 30, 2025 | -6.27% |
| Jun 30, 2025 | -8.21% |
| Mar 31, 2025 | -18.96% |
| Dec 31, 2024 | -16.51% |
| Sep 30, 2024 | -16.94% |
| Jun 30, 2024 | -16.87% |
| Mar 31, 2024 | -14.92% |
| Dec 31, 2023 | 5.46% |
| Sep 30, 2023 | 63.85% |
| Jun 30, 2023 | 129.71% |
| Mar 31, 2023 | 683.92% |
| Dec 31, 2022 | 631.05% |
| Sep 30, 2022 | 559.49% |
| Jun 30, 2022 | 351.31% |
| Mar 31, 2022 | -100.00% |
| Dec 31, 2021 | 34.20% |
| Dec 31, 2020 | 151.12% |
| Dec 31, 2019 | 22.33% |
| Sep 30, 2019 | 157.53% |